Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


MEDA Pharma GmbH & Co. KG

MEDA Pharma GmbH & Co. KG Patent applications
Patent application numberTitlePublished
20120076739Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases - The invention relates to novel combinations based on anticholinergics, β03-29-2012
20080300226Combination of Anticholinergics and Glucocorticoids for the Long-Term Treatment of Asthma and COPD - The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.12-04-2008

Patent applications by MEDA Pharma GmbH & Co. KG